牛牛AI助理已提取核心訊息
Canopy Growth Corporation, a leading company in the cannabis industry, has been informed by the United States Securities and Exchange Commission (SEC) that its recent Registration Statement on Form S-1, filed on January 26, 2024, will not undergo review by the agency. The SEC's communication, dated January 31, 2024, was addressed to David Klein, CEO of Canopy Growth, and clarified that the responsibility for the accuracy and adequacy of disclosures in the registration statement lies with the company and its management. The SEC also referenced Rules 460 and 461, which pertain to requests for acceleration of the registration process. Canopy Growth has been advised to contact Alan Campbell from the SEC's Division of Corporation Finance, Office of Life Sciences, for any further inquiries.
Canopy Growth Corporation, a leading company in the cannabis industry, has been informed by the United States Securities and Exchange Commission (SEC) that its recent Registration Statement on Form S-1, filed on January 26, 2024, will not undergo review by the agency. The SEC's communication, dated January 31, 2024, was addressed to David Klein, CEO of Canopy Growth, and clarified that the responsibility for the accuracy and adequacy of disclosures in the registration statement lies with the company and its management. The SEC also referenced Rules 460 and 461, which pertain to requests for acceleration of the registration process. Canopy Growth has been advised to contact Alan Campbell from the SEC's Division of Corporation Finance, Office of Life Sciences, for any further inquiries.
美國證券交易委員會（SEC）已告知大麻行業的領先公司Canopy Growth Corporation，其最近於2024年1月26日提交的S-1表格註冊聲明不會經過該機構的審查。美國證券交易委員會於2024年1月31日致函Canopy Growth首席執行官戴維·克萊因，並澄清說，註冊聲明中披露的準確性和充分性由公司及其管理層負責。美國證券交易委員會還引用了與加快註冊程序的請求有關的第460和461條。已建議Canopy Growth聯繫美國證券交易委員會生命科學辦公室公司財務部的艾倫·坎貝爾，進行進一步的查詢。
美國證券交易委員會（SEC）已告知大麻行業的領先公司Canopy Growth Corporation，其最近於2024年1月26日提交的S-1表格註冊聲明不會經過該機構的審查。美國證券交易委員會於2024年1月31日致函Canopy Growth首席執行官戴維·克萊因，並澄清說，註冊聲明中披露的準確性和充分性由公司及其管理層負責。美國證券交易委員會還引用了與加快註冊程序的請求有關的第460和461條。已建議Canopy Growth聯繫美國證券交易委員會生命科學辦公室公司財務部的艾倫·坎貝爾，進行進一步的查詢。
有用
沒用